As a lean biotech with ambitious goals, Fulcrum Therapeutics needed to maximize R&D speed and productivity. Given the highly competitive environment, speed was essential for filing and protecting IP, as well as for quickly moving potential therapies into clinical development.
The Science Exchange SaaS-enabled marketplace was designed to solve the project initiation challenges for emerging biotech R&D organizations. By eliminating the need and time delay to establish one-off provider contracts and by integrating directly with existing IT infrastructure, Science Exchange enables biotech companies to focus immediately on execution. […]
